The applications of energy-based technologies for the ablative treatment of tissue are numerous and diverse as a result of the effectiveness of these technologies — which vary widely by energy type (electrosurgery, radiosurgery, gamma knife, brachytherapy, cryogenic therapy, fluidjet/hydrotherapy, microwave ablation, radiofrequency ablation, laser, thermal ablation, and ultrasonic ablation) — and their integration into routine [...]
PRLog (Press Release) – Jun 09, 2010 – The practice of surgery has long employed energy-based technologies to excise, cut, ablate, cauterize, destroy or otherwise manipulate tissue to produce therapeutic results. Various energy modalities — from cryotherapy to microwave to radiofrequency to ultrasound to radiation and others — have proven their ability to effect healthy or diseased tissue [...]
The evolution of treatments for coronary artery disease has historically been dynamic and, with the stakes still high for effective treatment and many different technologies in active development by medtech manufactures, that evolution will be continuing shift over the coming years. Setting aside, for the moment, the trends in coronary artery bypass graft surgery, encompassing [...]
As a follow-up to the recent decision by the FDA to approve Nycomed's TachoSil absorbable fibrin sealant patch for cardiovascular applications, we wanted to highlight that the cardiovascular arena offers one of the more promising areas for expanded use of surgical sealants and glues. Cardio applications represent a significant volume of procedures in which the [...]
Below are select technologies under development at recently identified medtechs startups: Scaffold for regeneration of functional bone tissues. Autologous, adipose-derived stem cells for treatment of traumatic brain injury and chronic obstructive pulmonary disease. Device company developing technologies to improve the safety and efficiency of chemotherapy. Developing stem cell therapies. Devices to locate and protect nerves [...]
Fibrin and other medical/surgical sealants have developed a broad repertoire of applications supported by their utility addressing different wound and tissue types. Below is a sampling of applications of fibrin and other sealants: Local hemostatic measures for both surgical and trauma cases Surgery in patients with bleeding disorders (e.g., hemophilia, severe thrombocytopenia) and non-bleeding cases [...]
Translation: Drug-eluting stents are to bare metal stents as bare metal stents were to percutaneous transluminal coronary angioplasty alone. In the September 1 post on the meta-analysis by researchers at Tuft Medical Center, we noted the overall findings in general terms of the value of drug-eluting stents compared to bare metal stents. It is worthwhile to [...]
(Report updated. See 2010 report on Ablation Technologies Worldwide.) The global market for medical devices is $200 billion opportunity and at least 13% of this market involves products that provide the controlled application of energy to tissue. The segment is dominated by high technology products ranging from devices that can heat and cool tissue over [...]
High-strength glue products were approved for topical closure applications in the United States in the late 1990s. Outside the United States, high-strength glues and adhesives have been approved in some countries for a number of years and have built up a track record of use in internal surgery. With time, high-strength glues will come to [...]
In cardiovascular and spine surgery, multi-billion dollar markets were created from entirely new procedures between 1980 and 2000, with subsequent segmentation in later years particularly as new minimally invasive procedures were developed towards the end of the 20th century. In the cardiovascular arena, the development of new procedures for angioplasty and bypasses in the late [...]
Contact:
